Workflow
GS Global Equities Call
Goldman Sachs·2024-08-12 08:01

Investment Rating - The report indicates a mixed sentiment with specific companies receiving upgrades and downgrades, reflecting a cautious approach towards the market [14]. Core Insights - The report highlights a significant amount of deleveraging across the risk complex, suggesting forced risk transfer among market participants [3]. - There is an expectation of continued economic expansion rather than recession, supported by a recent increase in labor supply and healthy labor market indicators [4]. - The report notes that momentum factors are diverging from consensus secular themes, indicating a shift in market dynamics [5]. Company-Specific Summaries TMT Sector - ARM ADRs upgraded to Outperform with a price target of 130[9].BMBLdowngradedtoHoldwithapricetargetof130 [9]. - BMBL downgraded to Hold with a price target of 6.50 due to poor growth [9]. - HUBS raised to Sector Weight, indicating positive sentiment despite macro headwinds [9]. Healthcare Sector - CRL downgraded to Neutral with a price target of 191[10].NVROupgradedtoPeerperform,reflectingimprovedoutlook[10].MCKloweredFY25revenuegrowthguidance,indicatingpotentialchallengesahead[10].ConsumerSectorKVYOupgradedtoOverweightwithapricetargetof191 [10]. - NVRO upgraded to Peerperform, reflecting improved outlook [10]. - MCK lowered FY25 revenue growth guidance, indicating potential challenges ahead [10]. Consumer Sector - KVYO upgraded to Overweight with a price target of 33, reflecting strong performance [11]. - MNST missed expectations and flagged a category slowdown, indicating potential headwinds [11]. - BROS downgraded due to a downturn in growth outlook and lower unit development guidance [11]. Industrials/Mats Sector - ASH upgraded to Neutral with a price target of 89,indicatingamorefavorableoutlook[12].WLKratedNewOutperformwithapricetargetof89, indicating a more favorable outlook [12]. - WLK rated New Outperform with a price target of 170, suggesting strong potential [12]. - TXT downgraded to Equal-Weight with a price target of $95, reflecting a cautious stance [12].